In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide

• Published in: Polymer degradation and stability 2009-02, Vol.94 (2), p.176-182
• Main Authors: Niu, Xufeng, Feng, Qingling, Wang, Mingbo, Guo, Xiaodong, Zheng, Qixin
• Format: Article
• Language: English
• Subjects: Applied sciences; Biological and medical sciences; Chitosan; Composites; Controlled delivery; Exact sciences and technology; Forms of application and semi-finished materials; Medical sciences; Microspheres; Poly(lactic acid); Polymer industry, paints, wood; Scaffolds; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Technology of polymers; Technology. Biomaterials. Equipments; Tissue engineering
• ISSN: 0141-3910; 1873-2321
• DOI: 10.1016/j.polymdegradstab.2008.11.008

To develop a novel tissue engineering scaffold with the capability of controlled releasing BMP-2-derived synthetic peptide, porous poly(lactic acid)/chitosan microspheres (PLA/CMs) composites containing different quantities of chitosan microspheres were prepared by a thermally induced phase separation method. FTIR analysis revealed that there were strong hydrogen bond interactions between the PLA and chitosan component. Introduction of less than 30% CMs (on PLA weight basis) did not remarkably affect the morphology and porosity of the PLA/CMs scaffolds. The compressive strength of the composite scaffolds increased from 0.48 to 0.66 MPa, while the compressive modulus increased from 7.29 to 8.23 MPa as the microspheres' contents increased from 0% to 50%. In vitro degradability investigation indicated that the dissolution of chitosan component was preferential than PLA matrix and the inclusion of CMs could neutralize the acidity of PLA degradation products. Compared with the rapid release from CMs, the synthetic peptide was released from PLA/CMs scaffolds in a temporally controlled manner, mainly depending on the degradation of PLA matrix. The promising microspheres based scaffold release system can be used to deliver bioactive factors for a variety of non-loaded bone regeneration and tissue engineering application.